Haemophilia trials in Hong Kong

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  Where

  Hong Kong, Ma Liu Shui

  Age

  1 year to 74 years

  People

  245 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05145127 · EU 2022-500470-33-00
• Phase 3Taking people
  Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

  Where

  Hong Kong, Shatin

  Age

  18 years and over

  People

  35 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT06003387 · EU 2023-509590-23-00